Date post: | 27-Dec-2015 |
Category: |
Documents |
Upload: | gordon-henry |
View: | 218 times |
Download: | 3 times |
The European Society’s HERMES The European Society’s HERMES Project, a Model to EmulateProject, a Model to Emulate
Francesco BlasiDepartment Pathophysiology and Transplantation,
University of Milan, Italy
Disclosures
• I have accepted grants, speaking and conference invitations from Almirall, Angelini, AstraZeneca, Bayer, Chiesi, GSK, Guidotti-Malesci, Menarini, Novartis, Pfizer, and Zambon
• I have had recent or ongoing consultancy with Almirall, Angelini, AstraZeneca, GSK, Menarini, Mundipharma and Novartis
EU CONTEXT: Free access and mobility
• EU mutual recognition of diplomas and certificates of qualification in medicine in all member countries
• EU parliament 2013 modernised the 2005 directive (Directive 2013/55/EU)– Modernisation of the definition for harmonised minimum training
requirements for professions which benefit from automatic recognition
– For example for doctors, modernised directive clarifies that the basic medical education ought to be based on 5’500 training hours done within a minimum of 5 years
Preliminary Phase
Phase 4Phase 3 Phase 2Phase 1
Core Syllabus Completed Sept 06
Standards for Training Centres (not started)
European ExamFirst Oct 08
Core Curriculum Completed Sept 08
HERMES Project
Preliminary Phase
Phase 4Phase 3 Phase 2Phase 1
Core Syllabus Completed Sept 06
Standards for Training Centres (not started)
European ExamFirst Oct 08
Core Curriculum Completed Sept 08
HERMES Project
What does the What does the Examination look like?Examination look like?
• Knowledge-based only• Paper-based multiple-choice questionnaire (MCQ) in
English; 90 questions; 3 hrs • Blueprint for the content of the examination is the
consensus-based European syllabus (Breathe 2006; 3: 59-70) available in 24 languages at: http://hermes.ersnet.org/452-syllabus-dissemination.htm
Why take a European Why take a European Examination?Examination?
• Proof of Excellence: to demonstrate to patients and colleagues your commitment to high-quality life-long learning
• Mobility: if moving to another country, the European Diploma will certainly be known and recognised within the profession
• Self-assessment: you may wish to find out where you stand against the current European standard
• Tangible recognition: European Diploma and membership of ERS School Diplomate Club
Advantages for the individual:
The European Diploma The European Diploma in Adult Respiratory in Adult Respiratory
MedicineMedicine
Re-validation:
To comply with European Curriculum recommendations (Breathe Sept 2008; volume 5, number 1), candidates are advised to voluntarily re-sit the European Examination every 5 years to demonstrate that their knowledge is up-to-date.
It is mandatory to re-sit the Examination every 10 years or the right to hold the Diploma will lapse.
SIMER INTERNATIONAL SIMER INTERNATIONAL SCHOOLSCHOOL
- Lectures Review of current guidelines
- Interactive sessions MCQ Clinical Cases
SIMER INTERNATIONAL SIMER INTERNATIONAL SCHOOLSCHOOL
A 24-year-old woman has had a long-standing mild, persistent asthma for which she has been using approximately four puffs (44 mcg/puff) per day od inhaled fluticasone and approximately two to four puffs of albuterol per week with good results. However, approximately 6 months ago, she and her husband bought and moved into a new house, which they are living in and slowly renovating. Although the main triggers to her asthma are believed to be cats and ragweed, she has noted a deterioration in her asthma since they moved in, despite multiple steps to limit her potential exposure to dust and mold during renovations. She has continued her fluticasone at the same dose but is now using two puffs of albuterol four to six times per day. She awakens because of asthma symptoms approximately once per week, and although she has not curtailed her regular activities, she reports feeling “more winded than usual”.Physical examination results are notable only for rare scattered wheezes on exhalation. FEV1 is 2.99 L (74% predicted), and FVC is 4.69 (98% predicted): the flow-volume loop shows mild expiratory coving.Assuming that no additional opportunities for trigger avoidance are identified, what is the most appropriate next step in her pharmacologic management?
A.Add a long-acting B-agonist to her current dose of inhaled fluticasone
B.Add montelukast to her current dose of inhaled fluticasone
C.Add omalizumab therapy to her current dose of inhaled fluticasone
D.Change her dose of inhaled fluticasone to four puffs bid of the 220 mcg/puff
Existing country collaborations
ADULT
•Switzerland
•Netherlands
•Russia
•Spain
•Portugal
•Austria
•Ireland
PAEDIATRIC
•UK
Feedback collated from centres The opportunity to be part of a Pan-European network of centres To benchmark trainee facilities and educational opportunities To receive recommendations on how to improve To present to the national ministry of health (for example) any basic standards
not met which will justify requests for additional budget for training and facilities
From an ers perspective
Bridge the gap between European criteria and local implementation
Ers handbooks
• ERS Handbook Series– 2nd edition Respiratory Medicine
– Respiratory Sleep Medicine
– Self-Assessment in Respiratory Medicine
– Paediatric Respiratory Medicine
Accreditation of Training Centres
Assessments
Preliminary Phase
Syllabus
HERMES Project Phases
Continuous Professional Development and
accreditation
Continuous Professional Development and
accreditation
Curriculum
Anal
ysis
of t
rain
ing
&
certi
ficati
on
Anal
ysis
of t
rain
ing
gap
Educational ResourcesEducational ResourcesPublished OutputsPublished Outputs
Phase 1 & 2Phase 1 & 2 Phase 3, 4 and 5Phase 3, 4 and 5Phase 3, 4 and 5Phase 3, 4 and 5
Standardsand
Frameworks
Adult Respiratory Medicine, Paediatric Respiratory Medicine. Multidisciplinary groups eg Respiratory Critical Care, Respiratory Sleep medicine, Thoracic Oncology, incorporation of skills assessment in addition to knowledge based assessment (HERMES Exam + portfolio), involvement of AHPs, scientists and trained staff
Applicability and acceptability of standardsApplicability and acceptability of standards
Continuous processes considered
Consolidation
Unifying processes and ensure robust methodology
Investigation of outcomes on how standards are used
Strategies of implementation Value of criteria and how they impact training and the healthcare system
Linkages
CME/CPD opportunities Based on HERMES standards (syllabi, curricula, accreditation criteria etc)
UEMS and other EU entities Other ERS committees (guidelines, scientific etc)
EBAP Other professional associations
Training centres/networks Other local/national authorities
• Promoting state-of-the-art medical education (curriculum development, assessments, teaching and learning etc)
• Differences in acceptability and applicability of the recommendations in different countries
Finding the balance
HERMES challenges
• Translation (different languages) of educational standards and assessments
• Different lengths of training across EU countries
• Different organisation of training across EU countries
• Legal aspects of practice in various fields
• Availability of resources in different countries for training
• Legal adoption of educational standards and assessments
• Models of collaboration for accreditation (individuals, centres and
networks)
Hermes priorities
Consolidation of HERMES projects
Development of processes for implementation of educational standards
Scientific approach with the processes involved (including Delphi technique and measurements)
Development of the HERMES initiative as a European/regional approach
Developing CME/CPD standards for trained specialists
Exploration of legal aspects
Rigorous validation and commitment
in formulating the educational standards
through robust methodologies in medical
education.
The transnational nature of the hermes initiative highlights and addresses the current trend of
mobility among specialists and patients within Europe.